The 4B06-01 project with integration of multipronged AI-enabled approaches has successfully completed enrollment of all patients for the ALS Investigator-Initiated Trial

Recently, the 4B06-01 project with AI-empowerment from target discovery to the whole process of clinical trials has successfully enrolled all 64 patients.

First-in-Class Monoclonal Antibody 4B03-04 Got Approval in Australia for Clinical Study

On December 21, 2023, 4B Technology announced that FIC monoclonal antibody 4B03-04 has received approval from Alfred Clinical Research Ethics Committee to conduct clinica...

4B Technologies was selected into the list of "2023 China Biomedical Industry Front-runners 100”

Recently, 4B Biotechnologies was selected for the "2023 China Biomedical Industry Front-runners 100" list.